Home › Companies › KURA ONCOLOGY INC. › 2023-2024
Compiled from SEC Form N-PX filings and KURA ONCOLOGY INC.’s Form 8-K, filed 2024-06-07 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore KURA ONCOLOGY INC. in the interactive database Compare manager voting policies
These tallies are KURA ONCOLOGY INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-07 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Troy E. Wilson, Ph.D., J.D. | 59,332,182 | -- | -- | 7,740,382 | 2,690,089 | Majority: yes |
| Elect Director: Faheem Hasnain | 59,745,514 | -- | -- | 7,327,050 | 2,690,089 | Majority: yes |
| Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm | 69,596,811 | 56,740 | 109,102 | -- | -- | Majority: yes |
| Proposal 3. Advisory Vote on Executive Compensation | 61,538,693 | 5,449,767 | 111,285 | -- | 2,662,908 | Majority: yes |
| Proposal 4. Approval of our Amended 2014 Plan | 53,621,818 | 11,993,394 | 1,484,533 | -- | 2,662,908 | Majority: yes |
Source: KURA ONCOLOGY INC., Form 8-K, filed with the SEC on 2024-06-07 — read the filing on EDGAR.
Each item below shows how the 183 asset managers that disclosed a KURA ONCOLOGY INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of KURA ONCOLOGY INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 9 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
KURA ONCOLOGY INC.’s own tally for this item (“Proposal 3. Advisory Vote on Executive Compensation”): 61,538,693 for, 5,449,767 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 76,181,000 outstanding shares: 81% for, 7% against (88% of the company cast a for/against vote).
The 182 asset managers below cast 92% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| New York Life | 19,000,000 | 15,861 | 0 | 0 | For |
| State Street | 6,576,853 | 0 | 0 | 0 | For |
| BlackRock | 5,883,578 | 9,112 | 0 | 0 | For |
| EcoR1 Capital, LLC | 5,806,871 | 0 | 0 | 0 | For |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,570,766 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,411,571 | 0 | 0 | 0 | For |
| BVF INC/IL | 4,876,293 | 0 | 0 | 0 | For |
| Vanguard | 4,069,833 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 2,544,742 | 0 | 0 | 0 | For |
| Paradigm Biocapital Advisors LP | 2,398,541 | 0 | 0 | 0 | For |
| Foresite Capital Management IV, LLC | 1,849,947 | 0 | 0 | 0 | For |
| Fidelity | 1,774,276 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 1,738,699 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,705,203 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 30,929 | 1,510,138 | 0 | 0 | Against |
| COMMODORE CAPITAL LP | 1,525,000 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 1,423,642 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,198,054 | 0 | 0 | Against |
| Dimensional | 0 | 1,199,820 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 0 | 967,982 | 0 | 0 | Against |
| JPMorgan | 677,946 | 0 | 0 | 0 | For |
| Northern Trust | 653,817 | 733 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 651,398 | 0 | 0 | Against |
| Invesco | 448,236 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 412,663 | 0 | 0 | 0 | For |
Showing the 25 largest of 182 asset managers. See all 182 in the interactive database.
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
KURA ONCOLOGY INC.’s own tally for this item (“Proposal 4. Approval of our Amended 2014 Plan”): 53,621,818 for, 11,993,394 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 76,181,000 outstanding shares: 70% for, 16% against (86% of the company cast a for/against vote).
The 60 asset managers below cast 72% of the shares they voted on this item FOR (11,960,362 for, 4,555,563 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,968,562 | 0 | 0 | 0 | For |
| BlackRock | 3,144,096 | 0 | 0 | 0 | For |
| State Street | 27,922 | 2,563,728 | 0 | 0 | Against |
| Fidelity | 1,641,779 | 64,914 | 0 | 0 | For |
| Dimensional | 0 | 996,915 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 967,982 | 0 | 0 | 0 | For |
| Charles Schwab | 599,027 | 0 | 0 | 0 | For |
| JPMorgan | 305,460 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 213,276 | 0 | 0 | Against |
| Invesco | 203,663 | 0 | 0 | 0 | For |
| Equitable | 191,066 | 0 | 0 | 0 | For |
| TIAA | 175,690 | 0 | 0 | 0 | For |
| Russell Investments | 150,483 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,528 | 0 | 0 | 0 | For |
| Lincoln Financial | 25,564 | 95,714 | 0 | 0 | Against |
| American Century | 0 | 109,809 | 0 | 0 | Against |
| Goldman Sachs | 0 | 91,413 | 0 | 0 | Against |
| Exchange Place Advisors Trust | 84,620 | 0 | 0 | 0 | For |
| Northern Trust | 73,540 | 0 | 0 | 0 | For |
| ProShares | 0 | 64,795 | 0 | 0 | Against |
| Voya | 0 | 56,077 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 53,700 | 0 | 0 | Against |
| ALGERT GLOBAL LLC | 47,561 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 34,775 | 0 | 0 | Against |
| Brighthouse | 0 | 34,572 | 0 | 0 | Against |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 3 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
KURA ONCOLOGY INC.’s own tally for this item (“Elect Director: Faheem Hasnain”): 59,745,514 for, 7,327,050 withheld, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 76,181,000 outstanding shares: 78% for, 10% withheld (88% of the company cast a for/withheld vote).
The 58 asset managers below cast 100% of the shares they voted on this item FOR (14,540,147 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,968,562 | 0 | 0 | 0 | For |
| BlackRock | 3,144,096 | 0 | 0 | 0 | For |
| State Street | 2,554,088 | 0 | 37,562 | 0 | For |
| Fidelity | 1,706,693 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 996,915 | 0 | Abstain |
| FRANKLIN STRATEGIC SERIES | 967,982 | 0 | 0 | 0 | For |
| Charles Schwab | 599,027 | 0 | 0 | 0 | For |
| JPMorgan | 305,460 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 213,276 | 0 | Abstain |
| Invesco | 203,663 | 0 | 0 | 0 | For |
| Equitable | 107,966 | 0 | 83,100 | 0 | For |
| TIAA | 175,690 | 0 | 0 | 0 | For |
| Russell Investments | 150,483 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,528 | 0 | 0 | 0 | For |
| Lincoln Financial | 82,663 | 0 | 38,615 | 0 | For |
| American Century | 0 | 0 | 109,809 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 91,413 | 0 | Abstain |
| Exchange Place Advisors Trust | 84,620 | 0 | 0 | 0 | For |
| Northern Trust | 73,540 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 64,795 | 0 | Abstain |
| Voya | 56,077 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 0 | 0 | 53,700 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 34,775 | 0 | Abstain |
| Brighthouse | 0 | 0 | 34,572 | 0 | Abstain |
| Global X | 32,116 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 3 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
KURA ONCOLOGY INC.’s own tally for this item (“Elect Director: Troy E. Wilson, Ph.D., J.D.”): 59,332,182 for, 7,740,382 withheld, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 76,181,000 outstanding shares: 78% for, 10% withheld (88% of the company cast a for/withheld vote).
The 58 asset managers below cast 100% of the shares they voted on this item FOR (14,657,815 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,968,562 | 0 | 0 | 0 | For |
| BlackRock | 3,144,096 | 0 | 0 | 0 | For |
| State Street | 2,554,088 | 0 | 37,562 | 0 | For |
| Fidelity | 1,706,693 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 996,915 | 0 | Abstain |
| FRANKLIN STRATEGIC SERIES | 967,982 | 0 | 0 | 0 | For |
| Charles Schwab | 599,027 | 0 | 0 | 0 | For |
| JPMorgan | 305,460 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 213,276 | 0 | Abstain |
| Invesco | 203,663 | 0 | 0 | 0 | For |
| Equitable | 191,066 | 0 | 0 | 0 | For |
| TIAA | 175,690 | 0 | 0 | 0 | For |
| Russell Investments | 150,483 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,528 | 0 | 0 | 0 | For |
| Lincoln Financial | 82,663 | 0 | 38,615 | 0 | For |
| American Century | 0 | 0 | 109,809 | 0 | Abstain |
| Goldman Sachs | 91,413 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 84,620 | 0 | 0 | 0 | For |
| Northern Trust | 73,540 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 64,795 | 0 | Abstain |
| Voya | 0 | 0 | 56,077 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 53,700 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 34,775 | 0 | Abstain |
| Brighthouse | 0 | 0 | 34,572 | 0 | Abstain |
| Global X | 32,116 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
KURA ONCOLOGY INC.’s own tally for this item (“Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm”): 69,596,811 for, 56,740 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 76,181,000 outstanding shares: 91% for, 0.1% against (91% of the company cast a for/against vote).
The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (16,463,928 for, 4,436 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,968,562 | 0 | 0 | 0 | For |
| BlackRock | 3,144,096 | 0 | 0 | 0 | For |
| State Street | 2,587,214 | 4,436 | 0 | 0 | For |
| Fidelity | 1,706,693 | 0 | 0 | 0 | For |
| Dimensional | 996,915 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 967,982 | 0 | 0 | 0 | For |
| Charles Schwab | 599,027 | 0 | 0 | 0 | For |
| JPMorgan | 305,460 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 213,276 | 0 | 0 | 0 | For |
| Invesco | 203,663 | 0 | 0 | 0 | For |
| Equitable | 191,066 | 0 | 0 | 0 | For |
| TIAA | 175,690 | 0 | 0 | 0 | For |
| Russell Investments | 150,483 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,528 | 0 | 0 | 0 | For |
| Lincoln Financial | 121,278 | 0 | 0 | 0 | For |
| American Century | 109,809 | 0 | 0 | 0 | For |
| Goldman Sachs | 91,413 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 84,620 | 0 | 0 | 0 | For |
| Northern Trust | 73,540 | 0 | 0 | 0 | For |
| ProShares | 64,795 | 0 | 0 | 0 | For |
| Voya | 56,077 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 53,700 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 34,775 | 0 | 0 | 0 | For |
| Brighthouse | 34,572 | 0 | 0 | 0 | For |
| Global X | 32,116 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
82% Majority: yes · of votes cast
KURA ONCOLOGY INC.’s own tally for this item (“Proposal 4. Approval of our Amended 2014 Plan”): 53,621,818 for, 11,993,394 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 76,181,000 outstanding shares: 70% for, 16% against (86% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (28,891 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Simplify Exchange Traded Funds | 0 | 0 | 80,000 | 0 | Abstain |
| BOSUN ASSET MANAGEMENT, LLC | 28,891 | 0 | 0 | 0 | For |
Ranked by the number of KURA ONCOLOGY INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 76,181,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | New York Life | 24.96% |
| 2 | State Street | 8.63% |
| 3 | BlackRock | 7.74% |
| 4 | EcoR1 Capital, LLC | 7.62% |
| 5 | SUVRETTA CAPITAL MANAGEMENT, LLC | 7.31% |
| 6 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7.10% |
| 7 | BVF INC/IL | 6.40% |
| 8 | Vanguard | 5.34% |
| 9 | Avoro Capital Advisors LLC | 3.34% |
| 10 | Paradigm Biocapital Advisors LP | 3.15% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 12.49% | 13F |
| EcoR1 Capital, LLC | 10.09% | DEF14A |
| Suvretta Capital Management, LLC | 10.07% | DEF14A |
| BVF Partners L.P. | 10.02% | DEF14A |
| S | 9.81% | 13G |
| Deerfield Management Company, L.P. | 7.66% | DEF14A |
| Vanguard Group | 7.18% | 13F |
| State Street | 5.51% | 13F |
| Goldman Sachs | 3.43% | 13F |
| Troy E. Wilson, Ph.D., J.D. | 3.01% | DEF14A |
Percentages above are of 76,181,000 shares outstanding, as reported by KURA ONCOLOGY INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KURA ONCOLOGY INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At KURA ONCOLOGY INC.'s shareholder meeting held 2024-06-05, in the 2023-2024 proxy season, 183 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,102 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS DURING THE… — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: KURA ONCOLOGY INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-07.
KURA ONCOLOGY INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.